SCHEMBL23948105

SCHEMBL23948105

C[C@H](S)CCN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762908 1.00 — —
SCHEMBL19362272 1.00 — —
SCHEMBL8494551 0.82 — —
SCHEMBL20850665 0.82 — —
SCHEMBL2511403 0.78 TDP1 (0.44) —
SCHEMBL19788207 0.75 ALDH1A1 (0.34) —
SCHEMBL22088567 0.75 — —
SCHEMBL7162514 0.73 HTR2A (0.40) —
SCHEMBL141055 0.73 — —
SCHEMBL27306247 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210322575-A1 LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY NUTCRACKER THERAPEUTICS, INC. (US) 2021-10-21 — — US disclosed
Send feedback